Advertisement

Complex multisystem phenotype associated with the mitochondrial DNA m.5522G>A mutation

  • Claudia NestiEmail author
  • Anna Rubegni
  • Deborah Tolomeo
  • Jacopo Baldacci
  • Denise Cassandrini
  • Francesca D’Amore
  • Filippo M. SantorelliEmail author
Brief Communication
  • 26 Downloads

Abstract

Mitochondrial tRNAs are responsible for more than half of pathogenic point mutations in the mitochondrial genome (mtDNA). Different mutations give rise to widely differing phenotypes, ranging from isolated organ-specific diseases to multisystem conditions. Herein, we report a 40-year-old woman presenting with a complex multisystem phenotype including sensorineural hearing loss, retinopathy, severe dilated cardiomyopathy, non-insulin dependent diabetes mellitus, and renal failure. Sequence analysis of mtDNA identified the m.5522G>A mutation in MT-TW, the gene encoding mitochondrial tRNA for tryptophan. The heteroplasmic variant, thus far described once, was almost exclusively confined to skeletal muscle tissue, as shown by massive parallel sequencing and corroborated by an ad hoc designed PCR-based strategy. This patient, presenting a severe, multisystem involvement apparently sparing the brain, contributes to the genetic heterogeneity of mitochondrial diseases caused by mutations in mitochondrial tRNAs.

Keywords

mtDNA mutation Heteroplasmy tRNATrp Multisystem disorder Massive parallel sequencing 

Notes

Acknowledgments

We are indebted to Dr. Catherine J. Wrenn for expert editing of the manuscript and critical advice.

Funding information

This work was partially supported by grant MITONEXT (to FMS) and Ricerca Corrente 5x1000 2018 from the Italian Ministry of Health.

Compliance with ethical standards

All the procedures complied with the Helsinki Declaration of 1975. This study was approved by our institutional ethics committee.

Supplementary material

10072_2019_3864_MOESM1_ESM.docx (12 kb)
ESM 1 (DOCX 12 kb)

References

  1. 1.
    Tang S, Wang J, Zhang VW, Li FY, Landsverk M, Cui H, Truong CK, Wang G, Chen LC, Graham B, Scaglia F, Schmitt ES, Craigen WJ, Wong LJC (2013) Transition to next generation analysis of the whole mitochondrial genome: a summary of molecular defects. Hum Mutat 34:882–893CrossRefGoogle Scholar
  2. 2.
    Cassandrini D, Savasta S, Bozzola M, Tessa A, Pedemonte M, Assereto S et al (2006) Mitochondrial DNA deletion in a child with mitochondrial encephalomyopathy, growth hormone deficiency, and hypoparathyroidism. J Child Neurol 21:983–985CrossRefGoogle Scholar
  3. 3.
    Rubegni A, Ferrari AR, Pasquariello R, Canapicchi R, Santorelli FM, Nesti C (2018) Relapsing-remitting course of cystic leukoencephalopathy. Pediatr Neurol 89:63–65CrossRefGoogle Scholar
  4. 4.
    De Michele G, Sorrentino P, Nesti C, Rubegni A, Ruggiero L, Peluso S et al (2018) Reversible valproate-induced subacute encephalopathy associated with a MT-ATP8 variant in the mitochondrial genome. Front Neurol 9:728CrossRefGoogle Scholar
  5. 5.
    Barić I, Fumić K, Petković Ramadža D, Sperl W, Zimmermann FA, Muačević-Katanec D, Mitrović Z, Pažanin L, Cvitanović Šojat L, Kekez T, Reiner Ž, Mayr JA (2013) Mitochondrial myopathy associated with a novel 5522G>A mutation in the mitochondrial tRNA(Trp) gene. Eur J Hum Genet 21:871–875CrossRefGoogle Scholar
  6. 6.
    Sonney S, Leipzig J, Lott MT, Zhang S, Procaccio V, Wallace DC, Sondheimer N (2017) Predicting the pathogenicity of novel variants in mitochondrial tRNA with MitoTIP. PLoS Comput Biol 13:e1005867.  https://doi.org/10.1371/journal.pcbi.1005867 CrossRefGoogle Scholar
  7. 7.
    Yarham JW, Al-Dosary M, Blakely EL, Alston CL, Taylor RW, Elson JL et al (2011) A comparative analysis approach to determining the pathogenicity of mitochondrial tRNA mutations. Hum Mutat 32:1319–1325CrossRefGoogle Scholar
  8. 8.
    Cardaioli E, Mignarri A, Cantisani TA, Malandrini A, Nesti C, Rubegni A, Funel N, Federico A, Santorelli FM, Dotti MT (2018) Myoclonus epilepsy, retinitis pigmentosa, leukoencephalopathy and cerebral calcifications associated with a novel m.5513G>A mutation in the MT-TW gene. Biochem Biophys Res Commun 500:158–162CrossRefGoogle Scholar

Copyright information

© Fondazione Società Italiana di Neurologia 2019

Authors and Affiliations

  1. 1.Molecular Medicine for Neurodegenerative and Neuromuscular Diseases UnitIRCCS Stella Maris FoundationPisaItaly
  2. 2.Department of Clinical and Experimental MedicineUniversity of PisaPisaItaly

Personalised recommendations